Literature DB >> 16343109

Diabetic retinopathy, nephropathy and cardiovascular disease in a patient with GH gene deletion.

Zvi Laron, Dov Weinberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16343109     DOI： 10.1111/j.1365-2265.2005.02402.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  4 in total

Review 1.  The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes.

Authors:  Swapnil N Rajpathak; Marc J Gunter; Judith Wylie-Rosett; Gloria Y F Ho; Robert C Kaplan; Radhika Muzumdar; Thomas E Rohan; Howard D Strickler
Journal:  Diabetes Metab Res Rev       Date:  2009-01       Impact factor: 4.876

2.  Lifetime congenital isolated GH deficiency does not protect from the development of diabetes.

Authors:  Taísa A R Vicente; Ivina E S Rocha; Roberto Salvatori; Carla R P Oliveira; Rossana M C Pereira; Anita H O Souza; Viviane C Campos; Elenilde G Santos; Rachel D C Araújo Diniz; Eugênia H O Valença; Carlos C Epitácio-Pereira; Mario C P Oliveira; Andrea Mari; Manuel H Aguiar-Oliveira
Journal:  Endocr Connect       Date:  2013-06-15       Impact factor: 3.335

3.  Does Insulin Like Growth Factor-1 (IGF-1) Deficiency Have a "Protective" Role in the Development of Diabetic Retinopathy in Thalassamia Major Patients?

Authors:  Vincenzo De Sanctis; Carlo Incorvaia; Ashraf T Soliman; Giancarlo Candini; Alessia Pepe; Christos Kattamis; Nada A Soliman; Heba Elsedfy; Mohamed El Kholy
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-05-20       Impact factor: 2.576

Review 4.  Prolactin and vasoinhibin are endogenous players in diabetic retinopathy revisited.

Authors:  Jakob Triebel; Thomas Bertsch; Carmen Clapp
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-09       Impact factor: 6.055
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.